pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment

Detalhes bibliográficos
Autor(a) principal: Liu, Yuanfen
Data de Publicação: 2022
Outros Autores: Ran, Yingchun, Ge, Yu, Raza, Faisal, Li, Shasha, Zafar, Hajra, Wu, Yiqun, Paiva-Santos, Ana Cláudia, Yu, Chenyang, Sun, Meng, Zhu, Ying, Li, Fei
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/103446
https://doi.org/10.3390/pharmaceutics14030652
Resumo: Conventional antitumor chemotherapeutics generally have shortcomings in terms of dissolubility, selectivity and drug action time, and it has been difficult to achieve high antitumor efficacy with single-drug therapy. At present, combination therapy with two or more drugs is widely used in the treatment of cancer, but a shortcoming is that the drugs do not reach the target at the same time, resulting in a reduction in efficacy. Therefore, it is necessary to design a carrier that can release two drugs at the same site. We designed an injectable pH-responsive OE peptide hydrogel as a carrier material for the antitumor drugs gemcitabine (GEM) and paclitaxel (PTX) that can release drugs at the tumor site simultaneously to achieve the antitumor effect. After determining the optimal gelation concentration of the OE polypeptide, we conducted an in vitro release study to prove its pH sensitivity. The release of PTX from the OE hydrogel in the medium at pH 5.8 and pH 7.4 was 96.90% and 38.98% in 7 days. The release of GEM from the OE hydrogel in media with pH of 5.8 and 7.4 was 99.99% and 99.63% in 3 days. Transmission electron microscopy (TEM) and circular dichroism (CD) experiments were used to observe the microstructure of the peptides. The circular dichroism of OE showed a single negative peak shape when under neutral conditions, indicating a β-folded structure, while under acidic conditions, it presented characteristics of a random coil. Rheological experiments were used to investigate the mechanical strength of this peptide hydrogel. Furthermore, the treatment effect of the drug-loaded peptide hydrogel was demonstrated through in vitro and in vivo experiments. The results show that the peptide hydrogels have different structures at different pH values and are highly sensitive to pH. They can reach the tumor site by injection and are induced by the tumor microenvironment to release antitumor drugs slowly and continuously. This biologically functional material has a promising future in drug delivery for combination drugs.
id RCAP_3c7998a809dc5ec3f55421e2020db413
oai_identifier_str oai:estudogeral.uc.pt:10316/103446
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatmentcombination therapydrug deliveryhydrogelcancerpeptideConventional antitumor chemotherapeutics generally have shortcomings in terms of dissolubility, selectivity and drug action time, and it has been difficult to achieve high antitumor efficacy with single-drug therapy. At present, combination therapy with two or more drugs is widely used in the treatment of cancer, but a shortcoming is that the drugs do not reach the target at the same time, resulting in a reduction in efficacy. Therefore, it is necessary to design a carrier that can release two drugs at the same site. We designed an injectable pH-responsive OE peptide hydrogel as a carrier material for the antitumor drugs gemcitabine (GEM) and paclitaxel (PTX) that can release drugs at the tumor site simultaneously to achieve the antitumor effect. After determining the optimal gelation concentration of the OE polypeptide, we conducted an in vitro release study to prove its pH sensitivity. The release of PTX from the OE hydrogel in the medium at pH 5.8 and pH 7.4 was 96.90% and 38.98% in 7 days. The release of GEM from the OE hydrogel in media with pH of 5.8 and 7.4 was 99.99% and 99.63% in 3 days. Transmission electron microscopy (TEM) and circular dichroism (CD) experiments were used to observe the microstructure of the peptides. The circular dichroism of OE showed a single negative peak shape when under neutral conditions, indicating a β-folded structure, while under acidic conditions, it presented characteristics of a random coil. Rheological experiments were used to investigate the mechanical strength of this peptide hydrogel. Furthermore, the treatment effect of the drug-loaded peptide hydrogel was demonstrated through in vitro and in vivo experiments. The results show that the peptide hydrogels have different structures at different pH values and are highly sensitive to pH. They can reach the tumor site by injection and are induced by the tumor microenvironment to release antitumor drugs slowly and continuously. This biologically functional material has a promising future in drug delivery for combination drugs.MDPI2022-03-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/103446http://hdl.handle.net/10316/103446https://doi.org/10.3390/pharmaceutics14030652eng1999-4923Liu, YuanfenRan, YingchunGe, YuRaza, FaisalLi, ShashaZafar, HajraWu, YiqunPaiva-Santos, Ana CláudiaYu, ChenyangSun, MengZhu, YingLi, Feiinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-11-14T21:34:55Zoai:estudogeral.uc.pt:10316/103446Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:20:16.921109Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
title pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
spellingShingle pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
Liu, Yuanfen
combination therapy
drug delivery
hydrogel
cancer
peptide
title_short pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
title_full pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
title_fullStr pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
title_full_unstemmed pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
title_sort pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
author Liu, Yuanfen
author_facet Liu, Yuanfen
Ran, Yingchun
Ge, Yu
Raza, Faisal
Li, Shasha
Zafar, Hajra
Wu, Yiqun
Paiva-Santos, Ana Cláudia
Yu, Chenyang
Sun, Meng
Zhu, Ying
Li, Fei
author_role author
author2 Ran, Yingchun
Ge, Yu
Raza, Faisal
Li, Shasha
Zafar, Hajra
Wu, Yiqun
Paiva-Santos, Ana Cláudia
Yu, Chenyang
Sun, Meng
Zhu, Ying
Li, Fei
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Liu, Yuanfen
Ran, Yingchun
Ge, Yu
Raza, Faisal
Li, Shasha
Zafar, Hajra
Wu, Yiqun
Paiva-Santos, Ana Cláudia
Yu, Chenyang
Sun, Meng
Zhu, Ying
Li, Fei
dc.subject.por.fl_str_mv combination therapy
drug delivery
hydrogel
cancer
peptide
topic combination therapy
drug delivery
hydrogel
cancer
peptide
description Conventional antitumor chemotherapeutics generally have shortcomings in terms of dissolubility, selectivity and drug action time, and it has been difficult to achieve high antitumor efficacy with single-drug therapy. At present, combination therapy with two or more drugs is widely used in the treatment of cancer, but a shortcoming is that the drugs do not reach the target at the same time, resulting in a reduction in efficacy. Therefore, it is necessary to design a carrier that can release two drugs at the same site. We designed an injectable pH-responsive OE peptide hydrogel as a carrier material for the antitumor drugs gemcitabine (GEM) and paclitaxel (PTX) that can release drugs at the tumor site simultaneously to achieve the antitumor effect. After determining the optimal gelation concentration of the OE polypeptide, we conducted an in vitro release study to prove its pH sensitivity. The release of PTX from the OE hydrogel in the medium at pH 5.8 and pH 7.4 was 96.90% and 38.98% in 7 days. The release of GEM from the OE hydrogel in media with pH of 5.8 and 7.4 was 99.99% and 99.63% in 3 days. Transmission electron microscopy (TEM) and circular dichroism (CD) experiments were used to observe the microstructure of the peptides. The circular dichroism of OE showed a single negative peak shape when under neutral conditions, indicating a β-folded structure, while under acidic conditions, it presented characteristics of a random coil. Rheological experiments were used to investigate the mechanical strength of this peptide hydrogel. Furthermore, the treatment effect of the drug-loaded peptide hydrogel was demonstrated through in vitro and in vivo experiments. The results show that the peptide hydrogels have different structures at different pH values and are highly sensitive to pH. They can reach the tumor site by injection and are induced by the tumor microenvironment to release antitumor drugs slowly and continuously. This biologically functional material has a promising future in drug delivery for combination drugs.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-16
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/103446
http://hdl.handle.net/10316/103446
https://doi.org/10.3390/pharmaceutics14030652
url http://hdl.handle.net/10316/103446
https://doi.org/10.3390/pharmaceutics14030652
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1999-4923
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134095832252416